
The CEO of the Novo Nordisk Foundation, Mads Krogsgaard Thomsen, believes that David Julius and Ardem Patapoutian only won the Nobel Prize for medicine because the committee did not have time to properly evaluate the research behind the mRNA-based Covid-19 vaccines.
He does acknowledge that the winners have done an important bit of work within pain receptor research – Julius used capsaicin from peppers to research the nervous system, while Patapoutian has worked with touch sensors – but believes that the social consequences of the vaccines are more significant.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app